Cas:1421227-53-3 WS6 manufacturer & supplier

Chemical Name:WS6

CAS.NO:1421227-53-3

Synonyms:Benzeneacetamide, 4-[[6-[(cyclopropylcarbonyl)amino]-4-pyrimidinyl]oxy]-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-;N-(6-{4-[2-({4-[(4-Methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl}amino)-2-oxoethyl]phenoxy}-4-pyrimidinyl)cyclopropanecarboxamide;WS6;4-[[6-[(Cyclopropylcarbonyl)amino]-4-pyrimidinyl]oxy]-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzeneacetamide

Molecular Formula:C₂₉H₃₁F₃N₆O₃

Molecular Weight:568.590

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:744.1±60.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.630

PSA:99.69000

Exact Mass:568.240967

LogP:3.86

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like Benzeneacetamide, 4-[[6-[(cyclopropylcarbonyl)amino]-4-pyrimidinyl]oxy]-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-[[6-[(Cyclopropylcarbonyl)amino]-4-pyrimidinyl]oxy]-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzeneacetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(6-{4-[2-({4-[(4-Methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl}amino)-2-oxoethyl]phenoxy}-4-pyrimidinyl)cyclopropanecarboxamide Use and application,N-(6-{4-[2-({4-[(4-Methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl}amino)-2-oxoethyl]phenoxy}-4-pyrimidinyl)cyclopropanecarboxamide technical grade,usp/ep/jp grade.

Related News: During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. WS6 manufacturer Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.��s governing body. WS6 supplier During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. WS6 vendor Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.��s governing body. WS6 factory We manufacture APIs and drug manufacturers make medicines from APIs.